Jacqueline Cloos
Jacqueline Cloos
Research coordinator Pediatric Oncology/Hematology and Hematology, VU University Medical Center, Amsterdam
Verified email at vumc.nl
TitleCited byYear
Cell sensitivity assays: the MTT assay
J Van Meerloo, GJL Kaspers, J Cloos
Cancer cell culture, 237-245, 2011
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features
M Kool, J Koster, J Bunt, NE Hasselt, A Lakeman, P Van Sluis, D Troost, ...
PloS one 3 (8), e3088, 2008
Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein
R Oerlemans, NE Franke, YG Assaraf, J Cloos, I van Zantwijk, CR Berkers, ...
Blood 112 (6), 2489-2499, 2008
Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia
K De Keersmaecker, ZK Atak, N Li, C Vicente, S Patchett, T Girardi, ...
Nature genetics 45 (2), 186, 2013
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on …
D Averbuch, C Orasch, C Cordonnier, DM Livermore, M Mikulska, ...
haematologica 98 (12), 1826-1835, 2013
Molecular signature associated with bone marrow micrometastasis in human breast cancer
U Woelfle, J Cloos, G Sauter, L Riethdorf, F Jänicke, P Van Diest, ...
Cancer research 63 (18), 5679-5684, 2003
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis
M Smits, J Nilsson, SE Mir, PM van der Stoop, E Hulleman, JM Niers, ...
Oncotarget 1 (8), 710, 2010
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
GJ Schuurhuis, M Heuser, S Freeman, MC Béné, F Buccisano, J Cloos, ...
Blood 131 (12), 1275-1291, 2018
Genetic susceptibility to head and neck squamous cell carcinoma
J Cloos, MR Spitz, SP Schantz, TC Hsu, Z Zhang, H Tobi, BJM Braakhuis, ...
JNCI: Journal of the National Cancer Institute 88 (8), 530-535, 1996
In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma
SE Mir, PCDW Hamer, PM Krawczyk, L Balaj, A Claes, JM Niers, ...
Cancer cell 18 (3), 244-257, 2010
Molecular minimal residual disease in acute myeloid leukemia
M Jongen-Lavrencic, T Grob, D Hanekamp, FG Kavelaars, A Al Hinai, ...
New England Journal of Medicine 378 (13), 1189-1199, 2018
Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples
J Cloos, BF Goemans, CJ Hess, JW Van Oostveen, Q Waisfisz, S Corthals, ...
Leukemia 20 (7), 1217, 2006
Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML
IHIM Hollink, CM Zwaan, M Zimmermann, T Arentsen-Peters, R Pieters, ...
Leukemia 23 (2), 262, 2009
The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia
I Hubeek, RW Stam, GJ Peters, R Broekhuizen, JPP Meijerink, ...
British journal of cancer 93 (12), 1388, 2005
Impaired bortezomib binding to mutant β5 subunit of the proteasome is the underlying basis for bortezomib resistance in leukemia cells
NE Franke, D Niewerth, YG Assaraf, J van Meerloo, K Vojtekova, ...
Leukemia 26 (4), 757, 2012
Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes
J Cloos, EJC Nieuwenhuis, DI Boomsma, DJ Kuik, MLT Van Der Sterre, ...
Journal of the National Cancer Institute 91 (13), 1125-1130, 1999
Comprehensive analysis of transcriptome variation uncovers known and novel driver events in T-cell acute lymphoblastic leukemia
ZK Atak, V Gianfelici, G Hulselmans, K De Keersmaecker, AG Devasia, ...
PLoS genetics 9 (12), e1003997, 2013
Increased mutagen sensitivity in head‐and‐neck squamous‐cell carcinoma patients, particularly those with multiple primary tumors
J Cloos, BJM Braakhuis, I Steen, MP Copper, N De Vries, JJP Nauta, ...
International journal of cancer 56 (6), 816-819, 1994
Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia
BV Balgobind, IHIM Hollink, ST Arentsen-Peters, M Zimmermann, ...
haematologica 96 (10), 1478-1487, 2011
Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2
M Smits, SE Mir, RJA Nilsson, PM van der Stoop, JM Niers, VE Marquez, ...
PloS one 6 (1), e16282, 2011
The system can't perform the operation now. Try again later.
Articles 1–20